← Leaderboards
Larry J Anderson
Emory University
$1,008,400
Attributed
$1,008,400
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.8K · FY2015–23$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,008,400 · 2
By mechanism
R41$579,425 · 1
R21$428,975 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Octavio Ramilo$12,889,369
- Martin Lawrence Moore$6,408,187
- Philip J Santangelo$16,741,105
- Sang-Moo Kang$13,182,056
- Asuncion Mejias$2,044,603
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyMouse ModelImmunogenicMucous Body SubstanceLifeLungCessation Of LifeElderlyImmunityImmune ResponseInfantInfectionAntibodiesLower Respiratory Tract Structure2 Year OldCellsChildDesignAluminum SulfateFormalinGtp-Binding ProteinsHospitalizationAdultNovel Strategies
Grant awards (4)
F plus G RSV VLP Vaccine for Improved Safety and Efficacy$279,634
R41 · FY2023 · AI · contact PI
F plus G RSV VLP Vaccine for Improved Safety and Efficacy$299,791
R41 · FY2022 · AI · contact PI
Respiratory Syncytial Virus G proteins to improve safety/efficacy of vaccines$188,625
R21 · FY2016 · AI · contact PI
Respiratory Syncytial Virus G proteins to improve safety/efficacy of vaccines$240,350
R21 · FY2015 · AI · contact PI